A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients

NCT06322628 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Nash

Interventions

DRUG: VSA006
DRUG: Placebo

Sponsor

Visirna Therapeutics HK Limited